ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Overview of selected historical series of patients with malignant peritoneal mesothelioma treated with conventional therapies

Overview of selected historical series of patients with malignant peritoneal mesothelioma treated with conventional therapies
Authors Year Patients (n.) Treatment Median survival (months)
Rogoff 1973 12 Debulking (n = 6), RT (n = 7), ip 32P (n = 4) 13
Jones 1979 7 Systemic CT (n = 2) 6
Chahinian 1982 12 Systemic CT, RT 7
Antman 1988 16 Debulking, ip cisplatin + doxorubicin, RT 16.4
Kirmani 1988 19 Ip cisplatin 12
Van Gelder 1989 19 Surgery, systemic CT* 6
Markmann 1992 19 Ip cisplatin, ip mitomycin-C (n = 18) 9
Neumann 1999 74 Not stated 12 (mean)
Etabbakh 1999 15 Debulking (n = 9), systemic CT (n = 9), ip CT (n = 1) 12.5
De Pangher 2009 81 CRS + HIPEC (n = 7), debulking (n = 23), systemic CT (n = 45) 13
All the patients underwent the listed therapies, unless otherwise specified.
RT: radiation therapy; ip: intra-peritoneal; 32P: radioactive chromic phosphate; CT: chemotherapy; CRS: cytoreductive surgery; HIPEC: hyperthermic intraperitoneal chemotherapy.
* The number of patients undergoing the listed therapies was not stated.
From: Baratti D, Kusamura S, Deraco M. Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research. J Surg Oncol 2011; 103:822. https://onlinelibrary.wiley.com/doi/full/10.1002/jso.21787. Copyright © 2011 John Wiley & Sons Ltd. Reproduced with permission of John Wiley & Sons Inc. This image has been provided by or is owned by Wiley. Further permission is needed before it can be downloaded to PowerPoint, printed, shared or emailed. Please contact Wiley's permissions department on [email protected] or use the RightsLink service by clicking on the 'Request Permission' link accompanying this article on Wiley Online Library (http://onlinelibrary.wiley.com).
Graphic 130811 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟